UMC Ljubljana
Ljubljana, 1000, Slovenia
NCT Number: NCT03966417
In this prospective, controlled trial, patient after TAVI will be randomized to either exercise training or usual care group.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Ljubljana, 1000, Slovenia
Patients after transcatheter aortic valve replacement (TAVI) are particularly old and severely deconditioned and are thus likely to benefit from cardiac rehabilitation programs. In this controlled trial, patients after TAVI will be randomized to either exercise training or usual care.
The aim of our study is to compare the effect of exercise training vs. usual care on:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous exercise training 2 times per week for a period of 12 weeks.
Other names: Rehabilitation
Time frame: 3 months
ml/kg/min
Time frame: 3 months
% flow-mediated dilatation and arterial stiffness
Time frame: 3 months
coefficient
Time frame: 3 months
ng/l
Time frame: 3 months
microg/l
Time frame: 3 months
points
Time frame: 3 months
Estimated with digital high-resolution ECG
Time frame: 3 months
metres
Time frame: 3 months
Estimated with digital high-resolution ECG
Time frame: 3 months
beats/min
University Medical Centre Ljubljana
Other
Acronym: FitTAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06602609
Aortic Valve Disease, Aortic Valve Stenosis
London, United Kingdom
View Trial DetailsNCT05491070
Aortic Valve Disease, Aortic Valve Stenosis
Taipei, Taiwan
View Trial DetailsNCT01251328
Aortic Valve Disease, Aortic Valve Stenosis
Munich, Bavaria, Germany
View Trial DetailsNCT06773780
Aortic Valve Disease, Aortic Valve Stenosis
Istanbul, Turkey (Türkiye)
View Trial Details